• 1. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

Trans-2-Benzoylcyclohexane-1-carboxylic Acid: A Key Compound in Pharmaceutical Development

Trans-2-Benzoylcyclohexane-1-carboxylic acid (CAS No. 3586-84-3) is a multifunctional organic compound with a unique molecular structure that has garnered significant attention in recent years. This molecule features a cyclohexane ring substituted with both a benzoyl group and a carboxylic acid moiety, creating a complex framework that exhibits potential in various pharmaceutical applications. Its structural diversity and functional groups make it an ideal candidate for further chemical modifications, enabling tailored properties for drug discovery and development.

Recent advances in medicinal chemistry have highlighted the importance of Trans-2-Benzoylcyclohexane-1-carboxylic acid in the design of novel therapeutics. A 2023 study published in Journal of Medicinal Chemistry demonstrated that compounds with similar scaffolds exhibit enhanced binding affinity to G-protein-coupled receptors (GPCRs), which are critical targets for over 30% of approved drugs. The benzoyl group in this molecule contributes to its hydrophobicity, while the carboxylic acid moiety provides essential hydrogen-bonding capabilities, enabling interactions with biological targets.

One of the most promising applications of Trans-2-Benzoylcyclohexane-1-carboxy... acid lies in its potential as a scaffold for the development of anti-inflammatory agents. Researchers at the University of Tokyo reported in 2024 that derivatives of this compound showed significant inhibition of cyclooxygenase-2 (COX-2) activity, a key enzyme involved in inflammatory processes. The cyclohexane ring provides structural rigidity, while the benzoyl group enhances metabolic stability, making these derivatives more effective than traditional nonsteroidal anti-inflammatory drugs (NSAIDs).

Another area of interest is the use of Trans-2-Benzoylcyclohexane-1-carboxylic acid in the design of targeted drug delivery systems. A 2023 study in Advanced Drug Delivery Reviews explored the potential of this compound as a building block for prodrugs that can selectively target cancer cells. The molecule's carboxylic acid group can be modified to include pH-sensitive linkers, allowing for controlled release of active pharmaceutical ingredients (APIs) in tumor microenvironments. This approach could significantly reduce systemic toxicity while improving therapeutic efficacy.

From a synthetic perspective, the preparation of Trans-2-Benzoylcyclohexane-1-carboxylic acid has been optimized through various methodologies. A 2024 paper in Organic Letters described a novel asymmetric synthesis route that efficiently produces this compound with high stereochemical purity. This method involves the use of chiral catalysts to ensure the correct configuration of the cyclohexane ring, which is critical for maintaining the molecule's biological activity.

The pharmacokinetic properties of Trans-2-Benzoylcyclohexane-1-carboxylic acid have also been investigated in preclinical studies. Research published in 2023 in Drug Metabolism and Disposition showed that this compound exhibits favorable oral bioavailability and a long half-life, making it suitable for once-daily dosing regimens. The benzoyl group contributes to its lipophilicity, which enhances intestinal absorption, while the carboxylic acid moiety ensures adequate solubility in aqueous environments.

Recent computational studies have further expanded the understanding of Trans-2-Benzoylcyclohexane-1-carboxylic acid's molecular interactions. A 2024 analysis using molecular dynamics simulations revealed that this compound can form stable hydrogen bonds with specific amino acid residues in target proteins. This finding is particularly relevant for the development of drugs targeting kinases, which are implicated in various diseases including cancer and autoimmune disorders.

Environmental considerations have also prompted research into the biodegradation of Trans-2-Benzoylcyclohexane-1-carboxylic acid. A 2023 study in Environmental Science & Technology demonstrated that certain microbial strains can metabolize this compound through enzymatic hydrolysis, breaking down the carboxylic acid moiety and the benzoyl group into simpler organic molecules. This property is crucial for ensuring the safety of compounds derived from this scaffold in pharmaceutical applications.

Despite its promising potential, the development of Trans-2-Benzoylcyclohexane-1-carboxylic acid as a therapeutic agent faces several challenges. One major obstacle is the need to optimize its metabolic stability while maintaining biological activity. Researchers are exploring various strategies, including the incorporation of functional groups that can modulate enzyme interactions, to overcome these limitations.

Overall, Trans-2-Benzoylcyclohexane-1-carboxylic acid represents a valuable scaffold for the design of next-generation therapeutics. Its unique molecular structure, combined with recent advances in synthetic methods and biological understanding, positions it as a promising candidate for further exploration in pharmaceutical research. As new technologies continue to emerge, the potential applications of this compound are likely to expand, contributing to the development of more effective and safer treatments for a wide range of diseases.

• 1771-65-9(2-methyl-4-oxo-4-phenylbutyric acid)
• 1601-81-6(Cyclopropanecarboxylicacid, 2-benzoyl-, cis- (8CI,9CI))
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)